The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSosandar Regulatory News (SOS)

Share Price Information for Sosandar (SOS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.00
Bid: 11.50
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 1.00 (8.696%)
Open: 12.00
High: 12.75
Low: 12.00
Prev. Close: 12.00
SOS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results for the year ended 31 December 2011

27 Mar 2012 07:00

RNS Number : 1142A
Orogen Gold PLC
27 March 2012
 



Orogen Gold Plc

("Orogen" or the "Company")

 

Final Results for the Year Ended 31 December 2011

 

 

Orogen Gold Plc (AIM:ORE), the AIM listed mineral exploration company focussed on Gold exploration and development in eastern Europe, announces its final results for the year ended 31 December 2011 .

 

Corporate Highlights

 

·; Change of focus to new European gold exploration company

·; Orogen Gold Limited acquired

·; AIM re-admission, new ticker "ORE.L"

·; Highly experienced Board built- with fusion of expertise in Geology and Financial Services

 

Operational Highlights

 

·; Historic Deli Jovan mine workings fully accessed on all former operating levels

o 2km of mine shafts and drives cleared at Rusman and Gindusa over 7 months

·; Underground mapping and sampling programme complete

o Underground channel and grab sample assay results due towards end April 2012 which will guide drilling programme

·; Diamond drilling programme scheduled for early Q2 2012

·; New prospective gold targets discovered from soil sampling programme

o Follow up work to commence in Q2 2012 alongside drilling programme

 

Financial Summary

 

·; Cash at 31 December 2011 was £2,004,000

·; £549,000 spent on Deli Jovan with further expenditure of £397,000 required to achieve 55% earn-in to Deli Jovan Project

 

 

Chief Executive of Orogen Gold Plc, Ed Slowey, commented:

 

"I am very pleased with what we have achieved in 2011, from a standing start. Deli Jovan was a very interesting prospect to us, but one we knew would require significant input prior to the commencement of drilling. I am delighted that the work involved in clearing and dewatering the shafts at Rusman and Gindusa has run to schedule and is now complete.

 

"It is pleasing that we have been able to complete both soil sampling and underground sampling/structural mapping programmes at the site within less than a year. We now await the results of the underground sampling which will guide our drilling operation. We will simultaneously be following up on our soil sampling programme, where we will further investigate the anomalies previously highlighted through a surface trenching programme.

 

"The foundations are in place to make 2012 another year of significant progress for Orogen. We look forward to updating shareholders with operational developments as work progresses."

 

 

 

 

Orogen Gold Plc

Ed Slowey, CEO

Alan Mooney, FD

 

+353 1662 8395

 

 

Zeus Capital Limited

Nominated Adviser and Joint Broker

Ross Andrews/Tom Rowley

 

 

+44 (0)161 831 1512

XCAP Securities Plc

Joint Broker

Jon Bellis

 

 

 

+44 (0) 207 101 7070

Newgate Threadneedle

Financial PR

Guy McDougall/Josh Royston/ Terry Garrett

 

 

 

+44 (0) 207 653 9842

 

 

Notes to Editors

 

CEO Ed Slowey, PGeo, EuroGeol is a Competent Person as defined by various international instruments and takes responsibility for the release of this information.

 

The Deli Jovan gold project is in eastern Serbia, the site comprising two shallow underground gold mines at Rusman and Gindusa, about 6 kilometres apart along a major shear zone, that were last in production over seventy years ago.

 

 

 

 

 

 

 

 

 

 

 

Orogen Gold Plc

Consolidated statement of comprehensive income

For the year ended 31 December 2011

 

 

 

 

Notes

Year ended 31 December 2011

Audited 9 months to 31 December 2010

£'000

£'000

- Recurring administrative expenses

(372)

(128)

- Share based payments

14

(511)

(5)

- Impairment of investments in subsidiaries & associates

10

(200)

(100)

- AIM re-admission costs

(136)

-

- Investment acquisition costs

-

(202)

Administrative expenses

(1,219)

(435)

Operating loss

3

(1,219)

(435)

Finance income

4

5

-

Loss on ordinary activities before taxation

(1,214)

(435)

Income tax benefit / (expense)

6

-

-

Loss for the year

(1,214)

(435)

Other comprehensive income

-

-

Total comprehensive income for the year

(1,214)

(435)

Loss attributable to parent's equity holders

(1,214)

(435)

Pence

Pence

Loss per share - basic and diluted

7

(0.07)

(0.06)

 

 

 

 

 

 

Orogen Gold Plc

Consolidated statement of financial position

As at 31 December 2011

 

 

Notes

 31 December 2011

 31 December 2010

£'000

£'000

Assets

Non-current assets

Goodwill

9

3,173

 -

Investments

10

549

570

Total non-current assets

3,722

570

Current assets

Trade and other receivables

11

33

246

Cash and cash equivalents

12

2,004

1,546

Total current assets

2,037

1,792

Total assets

5,759

2,362

Equity and liabilities

Capital and reserves attributable to owners of the company

Share capital

13

2,567

2,016

Share premium

13

10,239

6,714

Share based payments reserve

14

516

5

Retained earnings

15

(7,726)

(6,512)

Total equity

5,596

2,223

Current liabilities

Trade and other payables

16

163

139

Total current liabilities

163

139

Total equity and liabilities

5,759

2,362

 

 

 

 

Orogen Gold Plc

Consolidated statement of cash flows

 

Notes

Year ended31 December 2011

 9 months to 31 December 2010

£'000

£'000

Cash flows from operating activities

Operating loss

3

(1,219)

(435)

Decrease / (Increase) in trade and other receivables

213

(246)

Increase in trade and other payables

24

65

Impairment loss on investments

200

100

Share based payments

511

5

Net cash flow from operating activities

(271)

(511)

Cash flow from investing activities

Payments to acquire investment in joint venture

10

(549)

-

Net cash inflow on acquisition of subsidiary

166

Net cash outflow on acquisition of associate

-

(370)

Finance income

5

-

Net cash flow from investing activities

(378)

(370)

Cash flow from financing activities

Net proceeds from issue of equity instruments

1,107

2,267

Net cash flow from financing activities

1,107

2,267

Net change in cash and cash equivalents

458

1,386

Cash and cash equivalents at beginning of period

12

1,546

160

Cash and cash equivalents at end of period

12

2,004

1,546

Balance sheet

2,004

1,546

 

 

 

 

Orogen Gold Plc

Consildated statement of changes in equity

Notes

Share capital

Share premium

Share based payments reserve

Retained earnings

Total equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 April 2010

1,158

5,305

-

(6,077)

386

Changes in period 1 April 2010 to 31 December 2010

Loss for the year

-

-

-

(435)

(435)

Issue of share capital

13

858

1,609

-

-

2,467

Share issue costs

13

-

(200)

-

-

(200)

Share based payments

14

-

-

5

5

Balance at 31 December 2010

2,016

6,714

5

(6,512)

2,223

Changes in year 1 January 2011 to

31 December 2011

Loss for the year

-

-

-

(1,214)

(1,214)

Issue of share capital

13

551

3,624

-

-

4,175

Share issue costs

13

-

(99)

-

-

(99)

Share based payments

14

-

-

511

-

511

Balance at 31 December 2011

2,567

10,239

516

(7,726)

5,596

 

 

 

 

 

 

 

 

For the remainder of the report and accounts please see the below link.

 

http://www.rns-pdf.londonstockexchange.com/rns/1142A_-2012-3-26.pdf

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR LLFFDVAIRFIF
Date   Source Headline
16th Apr 20247:00 amRNSFull Year Trading Update
10th Jan 20247:00 amRNSTrading Update
15th Dec 20237:00 amRNSBoard Changes
12th Dec 20237:00 amRNSHalf Year Results
29th Nov 20237:00 amRNSNotice of Results and Investor Presentations
9th Nov 20237:00 amRNSMello Investor Presentation
18th Oct 20237:00 amRNSTrading & Strategic Update
13th Oct 20237:00 amRNSNotice of Trading Update
5th Oct 20232:25 pmRNSHolding(s) in Company
21st Sep 20231:02 pmRNSResult of AGM
25th Aug 20239:45 amRNSNotice of AGM and Posting of Annual Report
11th Jul 20237:00 amRNSFinal Results
4th Jul 20237:00 amRNSNotice of Results and Investor Presentation
17th Apr 20233:13 pmRNSHolding(s) in Company
13th Apr 20232:28 pmRNSHolding(s) in Company
12th Apr 20237:00 amRNSTrading Update & Progress on Growth Strategy
16th Mar 20237:00 amRNSAppointment of Interim Non-Executive Chairman
3rd Mar 20238:12 amRNSDirector/PDMR Dealing
17th Feb 20233:54 pmRNSResult of Retail Offer
17th Feb 20237:00 amRNSClose of Retail Offer
14th Feb 20232:51 pmRNSHolding(s) in Company
13th Feb 202311:55 amRNSHolding(s) in Company
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:30 pmRNSResult of Placing
8th Feb 20239:16 amRNSRetail Offer
8th Feb 20237:00 amRNSProposed Placing to raise a minimum of £4 million
6th Feb 20237:00 amRNSDeath of Director
23rd Jan 20237:00 amRNSNew Third Party Arrangement
10th Jan 20237:00 amRNSTrading Update
13th Dec 20227:00 amRNSHalf Year Results
17th Nov 20227:00 amRNSNotice of Results and Investor Presentation
15th Nov 20225:25 pmRNSAIM Rule 17 Schedule 2(g) Update
18th Oct 20227:00 amRNSHalf Year Trading Update
15th Sep 20223:24 pmRNSResult of AGM & Notice of Trading Update
22nd Aug 20227:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20227:00 amRNSBoard Changes and Change of Auditor
12th Jul 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Results and Investor Presentation
10th Jun 20223:31 pmRNSDirector/PDMR Shareholding
6th May 202212:55 pmRNSDirector/PDMR Dealing
14th Apr 20227:00 amRNSBoard Appointment
6th Apr 20222:05 pmRNSSecond Price Monitoring Extn
6th Apr 20222:00 pmRNSPrice Monitoring Extension
6th Apr 20227:00 amRNSTrading Update and New Third Party Arrangements
6th Jan 20227:00 amRNSTrading Update
20th Dec 20219:00 amRNSExercise of Warrants and Total Voting Rights
30th Nov 20217:00 amRNSHalf Year Results
12th Nov 20217:00 amRNSNotice of Results
7th Oct 202111:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.